Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies
Open Access
- 30 October 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 30 (23) , 2838-2844
Abstract
Atherosclerosis constitutes the underlying disease to the clinical manifestations of myocardial infarction, stroke, and gangrene. Despite the success of statins, prevention of clinical events of atherosclerosis remains a major challenge in current-day cardiology. Research into the inflammatory nature of atherosclerosis has led to improved mechanistic understanding of its pathogenesis and to the identification of novel therapeutic targets discussed in this review. Recent genetic and epidemiological data document shared pathologies of chronic inflammatory diseases and atherosclerosis. Anti-inflammatory treatment regimens used in these diseases, including tumor necrosis factor-α blockade, IL-1 receptor antagonism, and leukotriene blockade may be beneficial also in patients with coronary artery disease. Enhancing inherent atheroprotective immunity by expansion of regulatory T cells may emerge as a future therapeutic strategy. Immunization strategies directed against atherosclerosis-related antigens such as epitopes within the low-density lipoprotein particle have been extensively studied in animal models and may enter the clinical stage. Success of these novel therapies will be critically dependent on the adequate identification of patients and choice of appropriate clinical endpoints.Keywords
This publication has 77 references indexed in Scilit:
- Independent Impact of Gout on Mortality and Risk for Coronary Heart DiseaseCirculation, 2007
- Risk of Myocardial Infarction in Patients With PsoriasisJAMA, 2006
- Global and regional burden of disease and risk factors, 2001: systematic analysis of population health dataThe Lancet, 2006
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarctionNature Genetics, 2005
- Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibilityNature Genetics, 2005
- Cardiovascular death in rheumatoid arthritis: A population‐based studyArthritis & Rheumatism, 2005
- Polymorphisms of the Interleukin-1β Gene Affect the Risk of Myocardial Infarction and Ischemic Stroke at Young Age and the Response of Mononuclear Cells to Stimulation In VitroArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Premature Coronary-Artery Atherosclerosis in Systemic Lupus ErythematosusNew England Journal of Medicine, 2003
- Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease EventsJAMA, 2003